Mindray Acquires HyTest from Summa Equity for €545 Million

Edgewater Capital Partners Acquires Haematologic Technologies

October 11, 2019

Biotechnology

Edgewater Capital Partners has entered into an agreement to acquire Haematologic Technologies Incorporated, a Vermont-based provider of biologic products, reagents and GMP-compliant assay development and testing services for the biopharmaceutical industry. Edgewater said it will support HTI's next phase of growth and build the company as a premier outsourced services partner for biologics; financial terms were not disclosed.

HORIBA Acquires MedTest Holdings (MedTest Dx, Pointe Scientific, Clinitox, Medical Laboratory Solutions)

February 3, 2021

Medical Devices

HORIBA, Ltd. (through HORIBA Instruments) acquired MedTest Holdings, Inc., including subsidiaries MedTest Dx, Pointe Scientific, Clinitox Diagnostix and Medical Laboratory Solutions, to expand HORIBA Medical's clinical chemistry and IVD reagent and instrument capabilities. The deal combines HORIBA Medical's Yumizen brand and distribution with MedTest/Pointe Scientific's R&D, manufacturing and regulatory (FDA 510(k)/CLIA) expertise to address multidisciplinary in‑vitro diagnostics (IVD) customer requirements.

Biogen Acquires Human Immunology Biosciences for up to $1.8B

May 22, 2024

Biotechnology

Biogen Inc. has agreed to acquire Human Immunology Biosciences (HI-Bio) for $1.15 billion upfront and up to $650 million in milestone payments, in a deal valued at up to $1.8 billion. The acquisition adds HI-Bio's lead asset felzartamab, an investigational anti-CD38 antibody with Phase 2 data in multiple renal immune-mediated diseases, to Biogen's immunology and rare-disease development capabilities.

Hologic, Inc. Acquires Mobidiag Oy

June 17, 2021

Medical Devices

Hologic, Inc. has completed the acquisition of Mobidiag Oy, a Finnish developer of near‑patient molecular diagnostic instruments and tests, for approximately $808 million. The deal expands Hologic's diagnostics capabilities by adding Mobidiag's Amplidiag and Novodiag platforms for rapid, multiplexed acute‑care testing and broadens Hologic's global diagnostics footprint.

Atlas Antibodies Acquires HistoCyte Laboratories Ltd

February 1, 2021

Medical Devices

Atlas Antibodies AB has signed an agreement to acquire UK-based HistoCyte Laboratories Ltd, a maker of cell-line control materials for immunohistochemical assays. The deal combines Atlas's proteome-wide antibody reagent portfolio with HistoCyte's novel control materials to expand diagnostic and research offerings; closing was expected in early March 2021.

Agilent Technologies to Acquire Biocare Medical for $950 Million

March 9, 2026

Healthcare Services

Agilent Technologies entered into a definitive agreement to acquire Biocare Medical, a global provider of clinical and research pathology solutions, in an all-cash transaction valued at $950 million. The deal is designed to expand Agilent’s pathology portfolio—especially immunohistochemistry—and is expected to close no later than Agilent’s fourth fiscal quarter of 2026.